hotspot -WSS

hotspot

author：hotspot 2025-09-27 12:58:13 - browse：7

NEW ORLEANS — For some patients suffering with certain blood cancers, CAR-T therapy can offer the tantalizing chance to end their disease with a single treatment.

But the immunotherapy takes time to manufacture, and patients often have to wait weeks to actually receive an infusion once they’re eligible. For some patients with especially aggressive cancer, they can die while waiting for the therapy to arrive.

That’s spurred CAR-T manufacturers to find ways to speed up manufacturing. The industry is testing newer — and possibly better — CAR-T cells that can be made more quickly. Researchers working with Novartis presented Phase 1 clinical trial data Sunday on a new CAR-T cell made with a rapid manufacturing process at the annual American Society of Hematology meeting.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： Pharma patents targeted by Biden in move to slash drug prices

WSS

SCOTUS to consider access to abortion pill mifepristone

Are infertility treatments 'essential' during the Covid

Pfizer plans to depart BIO

Pregnancy discrimination could be enabled by AI

Radiology is caught between AI's potential and concern for patients

Americans' trust in science, scientist continues decline: Report

focus

hotspot

entertainment

Bright Health sells Medicare Advantage business to Molina

Supreme Court wrestles with OxyContin maker's bankruptcy deal

Trump demands the U.S. pay no more for drugs than other countries … again

When a patient nears the end, a feared therapy can comfort

Bright Health sells Medicare Advantage business to Molina

Dementia risk linked to living in disadvantaged areas: Study

Drug repurposing or repositioning? The language matters

There’s a way to spot data fakery. All journals should be using it

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

STAT letters to the editor on burnt

focus

Extensive review finds private equity owners jack up cost of care

How a Boston hospital is priming medical residents to use GPT

Congenital heart disease patients face new threat of heart failure

Thousands of UK hospital doctors walk out in the latest pay dispute, crippling health services

Why sickle cell disease is getting the first CRISPR treatment

Thousands of UK hospital doctors walk out in the latest pay dispute, crippling health services

hotspot

knowledge

knowledge

leisure time